Amedisys (AMED) Shares Surge Despite Profitability Woes

By Emilio Sanchez • Monday, June 05 09:42 • Permanent Link

After moving 13.4% during today's morning session, Amedisys is now trading at a price of $90.15 per share. On average, analysts give it a target price of $93.15.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company's shares are down -30.8% over the last year and its Price to Book (P/B) ratio is currently 2.72.

Understanding Amedisys's Operating Margins

Date Reported	Total Revenue ($ k)	Operating Expenses ($ k)	Operating Margins (%)	YoY Growth (%)
2022-12-31	2,223,199	778,993	8.27	-27.33
2021-12-31	2,214,112	728,841	11.38	5.47
2020-12-31	2,071,519	662,730	10.79	17.92
2019-12-31	1,955,633	626,354	9.15	n/a

Amedisys's operating margins have averaged 9.9% over the last 4 years, which is significantly higher than the Medical and Nursing Services industry average of 4.07%. The firm's margins exhibit a relatively stable growth trend of -2.5%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.